dacarbazine has been researched along with Carcinoma, Small Cell Lung in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 10 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Goze, C; Pujol, CN; Pujol, JL; Roch, B | 1 |
| Amatulli, M; Balderes, P; Brennan, L; Burtrum, D; Credille, KM; Damoci, CB; DeLigio, JT; Duignan, IJ; Kotanides, H; Lebron, MB; Loizos, N; O'Mahony, M; Paz, K; Persaud, K; Prewett, MC; Schwartz, KD; Starodubtseva, M; Surguladze, D; Zhang, Y | 1 |
| Bergagnini, I; Drilon, A; Ginsberg, MS; Heguy, A; Holodny, AI; Huberman, K; Kadota, K; Kris, MG; Krug, LM; Pietanza, MC; Riely, GJ; Sima, CS; Sumner, DK; Travis, WD; Zauderer, MG | 1 |
| Boldorini, R; Buosi, R; Gaudino, E; Mancuso, G; Mercalli, F; Mezzapelle, R; Miglio, U; Paganotti, A; Rena, O; Veggiani, C | 1 |
| Muldoon, LL; Netto, JP; Neuwelt, EA; Pagel, MA | 1 |
| de Stanchina, E; Desmeules, P; Gardner, EE; Lok, BH; Ni, A; Poirier, JT; Powell, SN; Rekhtman, N; Riaz, N; Rudin, CM; Schneeberger, VE; Teicher, BA | 1 |
| Hiddinga, BI; Janssens, A; Pauwels, P; van Meerbeeck, JP | 1 |
| Krug, LM; O'Rourke, D; Pietanza, MC; Zauderer, M | 1 |
| Lee, FC; Mangalik, A; Movva, S; Parks, V; Rabinowitz, I; Verschraegen, CF | 1 |
| Azzoli, CG; Chan, TA; Fiore, JJ; Ginsberg, MS; Heguy, A; Holodny, AI; Huberman, K; Kadota, K; Kris, MG; Krug, LM; Pietanza, MC; Riely, GJ; Rizvi, NA; Sima, CS; Sumner, DK; Travis, WD | 1 |
2 review(s) available for dacarbazine and Carcinoma, Small Cell Lung
| Article | Year |
|---|---|
[Medical treatment of small cell lung cancer: Can we leave the area of cisplatin-etoposide?]
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Aurora Kinase A; Benzodiazepinones; Dacarbazine; DNA Damage; DNA Modification Methylases; DNA Repair; DNA Repair Enzymes; Enhancer of Zeste Homolog 2 Protein; Humans; Immunoconjugates; Lung Neoplasms; Poly(ADP-ribose) Polymerase Inhibitors; Protein Serine-Threonine Kinases; Receptors, Notch; Small Cell Lung Carcinoma; Temozolomide; Tumor Suppressor Proteins | 2018 |
O
Topics: Antineoplastic Agents, Alkylating; Brain Neoplasms; Carcinogenesis; Carcinoma, Non-Small-Cell Lung; Dacarbazine; DNA Methylation; DNA Modification Methylases; DNA Repair Enzymes; Epigenomics; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Neuroendocrine Tumors; O(6)-Methylguanine-DNA Methyltransferase; Predictive Value of Tests; Prognosis; Promoter Regions, Genetic; Small Cell Lung Carcinoma; Temozolomide; Treatment Outcome; Tumor Suppressor Proteins | 2017 |
3 trial(s) available for dacarbazine and Carcinoma, Small Cell Lung
| Article | Year |
|---|---|
Frequency of O⁶-methylguanine-DNA methyltransferase promoter methylation in cytological samples from small cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Biopsy, Fine-Needle; Dacarbazine; DNA Methylation; Glioma; Guanine; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; O(6)-Methylguanine-DNA Methyltransferase; Promoter Regions, Genetic; Small Cell Lung Carcinoma; Temozolomide | 2015 |
Phase I dose finding study of carboplatin, paclitaxel, and temozolomide in advanced solid tumors.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cohort Studies; Dacarbazine; Drug Administration Schedule; Female; Humans; Lung Neoplasms; Male; Maximum Tolerated Dose; Melanoma; Middle Aged; Paclitaxel; Skin Neoplasms; Small Cell Lung Carcinoma; Temozolomide | 2011 |
Phase II trial of temozolomide in patients with relapsed sensitive or refractory small cell lung cancer, with assessment of methylguanine-DNA methyltransferase as a potential biomarker.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Biomarkers, Tumor; Dacarbazine; DNA Methylation; Female; Humans; Lung Neoplasms; Male; Middle Aged; O(6)-Methylguanine-DNA Methyltransferase; Promoter Regions, Genetic; Recurrence; Small Cell Lung Carcinoma; Survival Analysis; Temozolomide; Treatment Outcome | 2012 |
5 other study(ies) available for dacarbazine and Carcinoma, Small Cell Lung
| Article | Year |
|---|---|
A human monoclonal antibody targeting the stem cell factor receptor (c-Kit) blocks tumor cell signaling and inhibits tumor growth.
Topics: Animals; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Cell Proliferation; Cisplatin; Dacarbazine; Etoposide; Female; Heterografts; Humans; Immunoglobulin G; Lung Neoplasms; Melanoma, Experimental; Mice, Nude; Mitogen-Activated Protein Kinase Kinases; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-kit; Signal Transduction; Small Cell Lung Carcinoma | 2014 |
Trial of a 5-day dosing regimen of temozolomide in patients with relapsed small cell lung cancers with assessment of methylguanine-DNA methyltransferase.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Dacarbazine; Drug Administration Schedule; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; O(6)-Methylguanine-DNA Methyltransferase; Small Cell Lung Carcinoma; Temozolomide; Treatment Outcome | 2014 |
Intra-arterial administration improves temozolomide delivery and efficacy in a model of intracerebral metastasis, but has unexpected brain toxicity.
Topics: Animals; Antineoplastic Agents, Alkylating; Blood-Brain Barrier; Brain Neoplasms; Dacarbazine; Drug Delivery Systems; Humans; Injections, Intra-Arterial; Lung Neoplasms; Male; Middle Aged; Neurotoxicity Syndromes; Rats; Rats, Nude; Small Cell Lung Carcinoma; Temozolomide; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2016 |
PARP Inhibitor Activity Correlates with SLFN11 Expression and Demonstrates Synergy with Temozolomide in Small Cell Lung Cancer.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Benzimidazoles; Cell Line, Tumor; Cisplatin; Dacarbazine; Drug Synergism; Etoposide; Gene Expression Regulation, Neoplastic; Genomics; Humans; Indoles; Mice; Nuclear Proteins; Phthalazines; Piperazines; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Small Cell Lung Carcinoma; Temozolomide; Xenograft Model Antitumor Assays | 2017 |
Leptomeningeal metastases from small cell lung cancer responsive to temozolomide therapy.
Topics: Antineoplastic Agents, Alkylating; Brain Neoplasms; Dacarbazine; Female; Humans; Lung Neoplasms; Male; Meningeal Neoplasms; Middle Aged; Small Cell Lung Carcinoma; Temozolomide; Treatment Outcome | 2010 |